Neurology · Lexington, KY
NPI
1427336890
Since 2011
Specialty
Neurology
Code 390200000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
740 S Limestone St, J 401
Lexington, KY, 40536
Phone (859) 323-5661
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
144 services
Medicare patients, 2024
68
Average age 64
Drug cost, 2024
$2.8M
1,217 prescriptions
Company payments, 2025
$14K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zabeen K Mahuwala was code 95720 (neurologic), 37 times for 20 patients. In total Zabeen K Mahuwala billed 144 services in 21 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 37 | 20 | $162.53 | $6,013 |
| 99215 Office E&M - Established | Office | 15 | 12 | $125.66 | $1,885 |
| 95718 Neurologic | Facility | 13 | 13 | $107.13 | $1,393 |
By year: 2022 $19K for 201 services; 2023 $15K for 177 services; 2024 $15K for 144 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zabeen K Mahuwala prescribed most often to Medicare patients was Gabapentin, with 101 prescriptions and refills. In total Zabeen K Mahuwala wrote 1,217 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 101 | 166 | 23 | $1,374 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 70 | 72 | Under 11 | $131K |
| Levetiracetam Generic | 67 | 158 | 23 | $3,367 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 63 | 65 | Under 11 | $603K |
| Rystiggo Rozanolixizumab-Noli | 58 | 58 | Under 11 | $1.1M |
| Lamotrigine Generic | 57 | 117 | 12 | $560 |
| Mycophenolate Mofetil Generic | 53 | 135 | 14 | $6,899 |
| Prednisone Generic | 48 | 98 | 13 | $389 |
| Lacosamide Generic | 46 | 64 | 11 | $7,977 |
| Pyridostigmine Bromide Generic | 42 | 117 | 17 | $7,351 |
| Briviact Brivaracetam | 38 | 38 | Under 11 | $68K |
| Pregabalin Generic | 32 | 42 | Under 11 | $1,013 |
| Mycophenolic Acid Mycophenolate Sodium | 29 | 41 | Under 11 | $10K |
| Phenobarbital Generic | 26 | 34 | Under 11 | $192 |
| Clonazepam Generic | 25 | 25 | Under 11 | $96.7 |
Brand drugs: 342 claims; generic drugs: 849 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zabeen K Mahuwala $14K ($14K in general payments such as food, travel and fees) from 10 companies. The largest payer was Amgen Inc. with $7,882.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 7 | $7,882 |
| Janssen Biotech, Inc. JNJ | 4 | $3,780 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $1,364 |
| UCB, Inc. UCB.BR | 7 | $377 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $197 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $135 |
| Biogen, Inc. BIIB | 3 | $85.76 |
| CSL Behring CSL.AX | 3 | $58.55 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $47.15 |
| Neurelis, Inc. | 1 | $20.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.